117 related articles for article (PubMed ID: 7128137)
21. Comparative metabolic effects of three types of combined oral contraceptive pills in Chinese women.
Prasad RN; Liew D; Ratnam SS
Contraception; 1989 Jan; 39(1):21-35. PubMed ID: 2521321
[TBL] [Abstract][Full Text] [Related]
22. Effects of medroxyprogesterone acetate on serum lipids, protein, glucose tolerance and liver function in Thai women.
Amatayakul K; Sivassomboon B; Singkamani R
Contraception; 1980 Mar; 21(3):283-97. PubMed ID: 6446443
[TBL] [Abstract][Full Text] [Related]
23. Influence of gestodene and desogestrel as components of low-dose oral contraceptives on the pharmacokinetics of ethinyl estradiol (EE2), on serum CBG and on urinary cortisol and 6 beta-hydroxycortisol.
Hammerstein J; Daume E; Simon A; Winkler UH; Schindler AE; Back DJ; Ward S; Neiss A
Contraception; 1993 Mar; 47(3):263-81. PubMed ID: 8462317
[TBL] [Abstract][Full Text] [Related]
24. Increased capillary permeability for plasma proteins in oral contraceptive users.
Tollan A; Kvenild K; Strand H; Oian P; Maltau JM
Contraception; 1992 May; 45(5):473-81. PubMed ID: 1385569
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of levonorgestrel and ethinylestradiol in 14 women during three months of treatment with a tri-step combination oral contraceptive: serum protein binding of levonorgestrel and influence of treatment on free and total testosterone levels in the serum.
Kuhnz W; Staks T; Jütting G
Contraception; 1994 Dec; 50(6):563-79. PubMed ID: 7705098
[TBL] [Abstract][Full Text] [Related]
26. Effects of three low-dose oral contraceptive formulations on lipid metabolism.
Bertolini S; Elicio N; Cordera R; Gapitanio GL; Montagna G; Croce S; Saturnino M; Balestreri R; De Cecco L
Acta Obstet Gynecol Scand; 1987; 66(4):327-32. PubMed ID: 2962417
[TBL] [Abstract][Full Text] [Related]
27. Effect of the combined steroidal contraceptives (Gynanovlar 21 and Lyndiol 2.5) on the human adrenocortical and ovarian activities.
Zaki K; Kamal I; Talaat MM; Rashad S; Nour H
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):41-65. PubMed ID: 12256027
[TBL] [Abstract][Full Text] [Related]
28. A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel.
Song S; Chen JK; Yang PJ; He ML; Li LM; Fan BC; Rekers H; Fotherby K
Contraception; 1992 Jun; 45(6):523-32. PubMed ID: 1535580
[TBL] [Abstract][Full Text] [Related]
29. Effect of some oral contraceptives on serum concentrations of sex hormone binding globulin and ceruloplasmin.
Song S; Chen JK; He ML; Fotherby K
Contraception; 1989 Apr; 39(4):385-99. PubMed ID: 2498034
[TBL] [Abstract][Full Text] [Related]
30. Oral contraceptives and plasma protein metabolism.
Briggs MH; Briggs M
J Steroid Biochem; 1979 Jul; 11(1B):425-8. PubMed ID: 226792
[TBL] [Abstract][Full Text] [Related]
31. Serum vitamin A and retinol-binding protein in malnourished women treated with oral contraceptives: effects of estrogen dose and duration of treatment.
Mohan Ram M; Bamji MS
Am J Obstet Gynecol; 1979 Oct; 135(4):470-2. PubMed ID: 573554
[TBL] [Abstract][Full Text] [Related]
32. Effect of levonorgestrel contraceptive implants, Norplant, on blood coagulation.
Shaaban MM; Elwan SI; el-Kabsh MY; Farghaly SA; Thabet N
Contraception; 1984 Nov; 30(5):421-30. PubMed ID: 6440738
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the metabolic effects of two hormonal contraceptive methods: an oral formulation and a vaginal ring. I. Carbohydrate metabolism and liver function.
Ahrén T; Victor A; Lithell H; Johansson ED
Contraception; 1981 Oct; 24(4):415-27. PubMed ID: 6797784
[TBL] [Abstract][Full Text] [Related]
34. Contraceptive steroid effects on nonreproductive organ systems.
Corson SL
J Reprod Med; 1986 Sep; 31(9 Suppl):865-78. PubMed ID: 3772906
[TBL] [Abstract][Full Text] [Related]
35. [Protein metabolism in women receiving Stediril-Wyeth preparation as a contraceptive].
Pisarek-Miedzińska D; Firek A; Korc R
Ginekol Pol; 1975 Jan; 46(1):33-7. PubMed ID: 45918
[TBL] [Abstract][Full Text] [Related]
36. Metabolic effects of two triphasic formulations containing ethinyl estradiol and dl-norgestrel.
Smith RP; Sizto R
Contraception; 1983 Aug; 28(2):189-99. PubMed ID: 6641221
[TBL] [Abstract][Full Text] [Related]
37. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
[TBL] [Abstract][Full Text] [Related]
38. [Liver function and iatrogenic anovulation].
Ramírez Sánchez J; Rojas L; Anzola F
Rev Colomb Obstet Ginecol; 1969; 20(1):11-7. PubMed ID: 5402152
[TBL] [Abstract][Full Text] [Related]
39. Serum bile acids in women taking combination contraceptives.
Donde UM; Potdar PD; Joshi UM; Saxena BN
Contraception; 1979 Dec; 20(6):579-83. PubMed ID: 119607
[TBL] [Abstract][Full Text] [Related]
40. The short-term effects of a low-dose oral contraceptive on glucose metabolism, plasma lipids and blood clotting factors.
Skouby SO; Wagner HH; Andersen O
Contraception; 1983 Nov; 28(5):489-99. PubMed ID: 6425010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
